At Blue Latitude Health, Brand Strategy encompasses the development and delivery of customer-focused strategies and plans, which create long-term value to patients and brands.
This is where you’ll find our commentary, articles, and resources that relate to those strategies and plans, and the processes behind them.
|29th September 2015
With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.
Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.
|23rd September 2015
Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.
|22nd July 2015
Recently, we’ve worked across multiple brands in oncology on launch and pre-launch strategy, which raises a unique set of challenges in a competitive and highly regulated market. Matt Bolton, Head of Commercial, takes us through the three key points to keep in mind when developing a pharmaceutical pre-launch positioning strategy.
|12th March 2015
The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by.
Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.
|8th September 2014
Although most companies have espoused the Multichannel Marketing concept, the pharma industry still presents considerable scope for developing and optimising the promotional mix. Deidre Coleman from EyeForPharma sat down with Managing Consultant James Atherton to discuss.
|31st July 2014
Proving ROI has been the main challenge to 28% of pharma executives in 2014. In the same way that digital is no longer an add-on to traditional marketing, ROI should be considered throughout the multichannel planning process and not just as a metric-focused process that is bolted on at the end of your multichannel planning. Read on for more.
|19th May 2014
Clients often contact us with the request to create a strategic, multichannel approach to connect with their audience and build the types of customer relationships that matter. Here are our top ten tips for effective multichannel marketing strategy and planning.
|16th December 2013
Whilst pharma companies have realised the importance of developing multichannel strategies, most are still on the journey to achieving multichannel excellence. Multichannel is about planning, implementing, and integrating multiple touch points and stakeholders to deliver improved return on investment. To achieve multichannel excellence, pharma must incorporate five core elements into their strategies in equal measure, broken down in this article.